Suppr超能文献

浸润大鼠结肠癌进展期和消退期肿瘤变体的淋巴细胞的细胞毒性活性

Cytotoxic activity of lymphocytes infiltrating progressive and regressive tumor variants from a rat colonic cancer.

作者信息

Pelletier H, Olsson N O, Lizard G, Martin F

机构信息

Research Group on Digestive Tumors, INSERM U.252, Faculty of Medicine, University of Dijon, France.

出版信息

Immunobiology. 1991 Mar;182(2):188-96. doi: 10.1016/S0171-2985(11)80203-2.

Abstract

Two tumor cell variants (PROb and REGb) isolated from a single chemically-induced rat colon adenocarcinoma were previously shown to differ in their tumorigenicity. When injected into syngeneic BDIX rats, PROb cells induce progressive tumors whereas REGb cells give rise to tumors which always regress. PROb and REGb variants also differ in their capacity to induce an immune response in the syngeneic host. Regression of REGb tumors could have been mediated by cytotoxic effector cells acting at the tumor site. To test this hypothesis, the cytolytic activity of non-adherent lymphoid cells isolated from PROb and REGb tumors and from the spleen of the same animals were compared. The same number of infiltrating lymphocytes was recovered per gram of PROb or REGb tumor. The cytolytic activity of tumor infiltrating lymphocytes, as that of spleen lymphocytes, was predominantly non specific, as demonstrated by their ability to kill YAC-1 cells, an NK-sensitive cell line. PROb cells were relatively resistant to the cytotoxic activity of spleen or tumor infiltrating lymphocytes. In the regressing REGb tumors, the cytotoxic activity of tumor infiltrating lymphocytes to homologous cells or to YAC-1 cells was low and significantly inferior to that of the corresponding spleen lymphocytes. These results suggest that the cytotoxic activity of lymphocytes was impaired at the local, intratumoral level, even in spontaneously regressing tumors.

摘要

先前从单一化学诱导的大鼠结肠腺癌中分离出的两种肿瘤细胞变体(PROb和REGb)在致瘤性方面存在差异。当注射到同基因的BDIX大鼠体内时,PROb细胞会诱发进行性肿瘤,而REGb细胞则会引发最终消退的肿瘤。PROb和REGb变体在同基因宿主中诱导免疫反应的能力也有所不同。REGb肿瘤的消退可能是由作用于肿瘤部位的细胞毒性效应细胞介导的。为了验证这一假设,比较了从PROb和REGb肿瘤以及相同动物脾脏中分离出的非贴壁淋巴细胞的细胞溶解活性。每克PROb或REGb肿瘤中回收的浸润淋巴细胞数量相同。肿瘤浸润淋巴细胞的细胞溶解活性与脾脏淋巴细胞一样,主要是非特异性的,这可通过它们杀死YAC-1细胞(一种NK敏感细胞系)的能力得到证明。PROb细胞对脾脏或肿瘤浸润淋巴细胞的细胞毒性活性相对具有抗性。在消退的REGb肿瘤中,肿瘤浸润淋巴细胞对同源细胞或YAC-1细胞的细胞毒性活性较低,且明显低于相应脾脏淋巴细胞。这些结果表明,即使在自发消退的肿瘤中,淋巴细胞的细胞毒性活性在局部肿瘤内水平也受到损害。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验